Ardent Health holders offer 8M shares in resale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Ardent Health, Inc. (ARDT) is named in a preliminary resale offering in which selling stockholders offer 8,000,000 common shares; underwriters may buy up to 1,200,000 additional shares from them within 30 days. Ardent will receive none of the proceeds from the stockholders’ sales.
Subject to completion of the offering, Ardent intends to repurchase up to 1,500,000 offered shares from the underwriters at the price they pay the selling stockholders, using cash on hand, and then cancel the repurchased shares. The offering is not conditioned on the repurchase. Assuming the full repurchase and no exercise of the underwriters’ option, 139,436,393 shares are expected to be outstanding afterward, compared with 140,936,393 shares outstanding as of November 2, 2026.
After the offering and repurchase, EGI-AM is expected to hold 70,109,780 shares and approximately 50.3% of voting power; it would hold approximately 49.5% if the option is exercised in full. Ardent would remain a controlled company under NYSE rules. Separately, Ardent entered an agreement to acquire Boone Health for $47 million, with closing expected in the first quarter of 2027, subject to customary closing conditions.
Filing Explained
EGI-AM’s board-nomination right depends on at least fifty percent voting power; the full-option scenario projects forty-nine point five percent.
This preliminary prospectus supplement describes a proposed resale by stockholders and an intended company repurchase, neither reported as completed. The repurchase is outside the existing stock-repurchase plan and would not reduce its remaining authorization. At
EGI-AM’s right to nominate a majority of directors is conditioned on holding at least
The cover leaves the public offering price and underwriting discount blank; the prospectus supplement states final terms of a specific takedown, so those sale economics are not established in this preliminary document.
Key Figures
Key Terms
Concurrent Share Repurchase financial
controlled company regulatory
underwriters’ option to purchase additional shares financial
beneficial ownership regulatory
lock-up agreements financial
Rule 144 regulatory
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ARDT shares are being sold in the offering?
Will Ardent Health receive proceeds from the ARDT share offering?
How much ARDT stock will EGI-AM own after the offering?
What does Ardent Health’s Boone Health acquisition include?
AI-generated analysis. How Rhea-AI works. Not financial advice.
To Prospectus dated August 25, 2025
| | | |
Per share
|
| |
Total
|
| ||||||
| Public offering price(1) | | | | $ | | | | | $ | | | ||
| Underwriting discounts and commissions(2) | | | | $ | | | | | | $ | | | |
| Proceeds, before expenses, to the selling stockholders(3) | | | | $ | | | | | | $ | | | |
| | J.P. Morgan | | |
Barclays
|
| |||
| |
BofA Securities
|
| | Citigroup | | |
Leerink Partners
|
| |
Mizuho
|
|
| |
RBC Capital Markets
|
| |
Stephens Inc.
|
| |
Truist Securities
|
|
| | | | |
Capital One Securities
|
| | | |
| | | |
Page
|
| |||
|
ABOUT THIS PROSPECTUS SUPPLEMENT
|
| | | | S-iii | | |
|
CAUTIONARY LANGUAGE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | S-iv | | |
|
PROSPECTUS SUPPLEMENT SUMMARY
|
| | | | S-1 | | |
|
RISK FACTORS
|
| | | | S-6 | | |
|
THE CONCURRENT SHARE REPURCHASE
|
| | | | S-10 | | |
|
USE OF PROCEEDS
|
| | | | S-11 | | |
|
MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR NON-U.S. HOLDERS
|
| | | | S-12 | | |
|
SELLING STOCKHOLDERS
|
| | | | S-15 | | |
| UNDERWRITING | | | | | S-16 | | |
|
LEGAL MATTERS
|
| | | | S-29 | | |
| EXPERTS | | | | | S-30 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | S-31 | | |
|
INCORPORATION BY REFERENCE
|
| | | | S-32 | | |
| | | |
Page
|
| |||
|
ABOUT THIS PROSPECTUS
|
| | | | ii | | |
| SUMMARY | | | | | 1 | | |
|
RISK FACTORS
|
| | | | 2 | | |
|
FORWARD-LOOKING STATEMENTS
|
| | | | 3 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 5 | | |
|
INFORMATION INCORPORATED BY REFERENCE
|
| | | | 6 | | |
|
USE OF PROCEEDS
|
| | | | 7 | | |
|
GENERAL DESCRIPTION OF SECURITIES
|
| | | | 8 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 9 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 14 | | |
|
SELLING STOCKHOLDERS
|
| | | | 26 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 28 | | |
|
LEGAL MATTERS
|
| | | | 33 | | |
| EXPERTS | | | | | 33 | | |
| | | |
Shares of common stock
|
| |||||||||||||||||||||||||||||||||||||||||||||
|
Name of beneficial owner
|
| |
Beneficially
owned before the offering and the concurrent share repurchase |
| |
Offered,
assuming underwriters’ option is not exercised |
| |
Beneficially
Owned After the Offering and the Concurrent Share Repurchase, Assuming Underwriters’ Option is Not Exercised |
| |
Offered,
Assuming Underwriters’ Option is Exercised in Full |
| |
Beneficially
Owned After the Offering and the Concurrent Share Repurchase, Assuming Underwriters’ Option is Exercised in Full |
| |||||||||||||||||||||||||||||||||
| |
Number
|
| |
%
|
| |
Number
|
| |
Number
|
| |
%
|
| |
Number
|
| |
Number
|
| |
%
|
| ||||||||||||||||||||||||||
|
EGI-AM Investments, L.L.C.(1)(3)
|
| | | | 77,246,499 | | | | | | 54.8% | | | | | | 7,136,719 | | | | | | 70,109,780 | | | | | | 50.3% | | | | | | 8,207,227 | | | | | | 69,039,272 | | | | | | 49.5% | | |
|
ALH Holdings, LLC(2)(3)
|
| | | | 9,342,501 | | | | | | 6.6% | | | | | | 863,281 | | | | | | 8,479,220 | | | | | | 6.1% | | | | | | 992,773 | | | | | | 8,349,728 | | | | | | 6.0% | | |
|
Underwriter
|
| |
Number of shares
|
| |||
|
J.P. Morgan Securities LLC
|
| | | | | | |
|
Barclays Capital Inc.
|
| | | | | | |
|
BofA Securities, Inc.
|
| | | | | | |
|
Citigroup Global Markets Inc.
|
| | | | | | |
|
Leerink Partners LLC
|
| | | | | | |
|
Mizuho Securities USA LLC
|
| | | | | | |
|
RBC Capital Markets, LLC
|
| | | | | | |
|
Stephens Inc.
|
| | | | | | |
|
Truist Securities, Inc.
|
| | | | | | |
|
Capital One Securities, Inc.
|
| | | | | | |
|
Total
|
| | | | 8,000,000 | | |
| | | | | | |
Total
|
| ||||||||||||
| | | |
Per share
|
| |
No exercise
|
| |
Full exercise
|
| |||||||||
|
Public offering price(1)
|
| | | $ | | | | | $ | | | | | $ | | | |||
|
Underwriting discounts and commissions borne by the selling stockholders(1)
|
| | | $ | | | | | $ | | | | | $ | | | |||
| |
Section 96(1) (a)
|
| | the offer, transfer, sale, renunciation or delivery is to: | |
| | | | |
(i)
persons whose ordinary business, or part of whose ordinary business, is to deal in securities, as principal or agent;
|
|
| | | | |
(ii)
the South African Public Investment Corporation;
|
|
| | | | |
(iii)
persons or entities regulated by the Reserve Bank of South Africa;
|
|
| | | | |
(iv)
authorised financial service providers under South African law;
|
|
| | | | |
(v)
financial institutions recognised as such under South African law;
|
|
| | | | |
(vi)
a wholly-owned subsidiary of any person or entity contemplated in (iii), (iv) or (v), acting as agent in the capacity of an authorised portfolio manager for a pension fund, or as manager for a collective investment scheme (in each case duly registered as such under South African law);
|
|
| | | | |
(vii)
any combination of the person in (i) to (vi); or
|
|
| | Section 96(1) (b) | | | the total contemplated acquisition cost of the securities, for any single addressee acting as principal is equal to or greater than ZAR1,000,000 or such higher amount as may be promulgated by notice in the Government Gazette of South Africa pursuant to section 96(2)(a) of the South African Companies Act. | |
340 Seven Springs Way, Suite 100
Brentwood, Tennessee 37027
(615) 296-3000
Attention: Investor Relations
Preferred stock
Debt securities
Offered by the Selling Stockholders
| | | |
Page
|
| |||
|
ABOUT THIS PROSPECTUS
|
| | | | ii | | |
| SUMMARY | | | | | 1 | | |
|
RISK FACTORS
|
| | | | 2 | | |
|
FORWARD-LOOKING STATEMENTS
|
| | | | 3 | | |
|
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 5 | | |
|
INFORMATION INCORPORATED BY REFERENCE
|
| | | | 6 | | |
|
USE OF PROCEEDS
|
| | | | 7 | | |
|
GENERAL DESCRIPTION OF SECURITIES
|
| | | | 8 | | |
|
DESCRIPTION OF CAPITAL STOCK
|
| | | | 9 | | |
|
DESCRIPTION OF DEBT SECURITIES
|
| | | | 14 | | |
|
SELLING STOCKHOLDERS
|
| | | | 26 | | |
|
PLAN OF DISTRIBUTION
|
| | | | 28 | | |
|
LEGAL MATTERS
|
| | | | 33 | | |
| EXPERTS | | | | | 33 | | |
340 Seven Springs Way, Suite 100
Brentwood, Tennessee 37027
(615) 296-3000
Attention: Investor Relations
| | | |
Shares of
Common Stock Beneficially Owned |
| |
Shares of
Common Stock That May be Sold Hereunder |
| |
Shares of Common Stock
Beneficially Owned After Sale of All Common Stock That May be Sold Hereunder(1) |
| |||||||||||||||||||||
|
Name of Selling Stockholder
|
| |
Shares
|
| |
Percentage
|
| |
Shares
|
| |
Percentage
|
| ||||||||||||||||||
|
EGI-AM(2)
|
| | | | 77,246,499 | | | | | | 54.0% | | | | | | 77,246,499 | | | | | | — | | | | | | — | | |
|
Pure Health(3)
|
| | | | 30,262,664 | | | | | | 21.1% | | | | | | 30,262,664 | | | | | | — | | | | | | — | | |
|
Ventas(4)
|
| | | | 9,342,501 | | | | | | 6.5% | | | | | | 9,342,501 | | | | | | — | | | | | | — | | |
|
David Vandewater(5)
|
| | | | 1,767,959 | | | | | | 1.2% | | | | | | 1,767,959 | | | | | | — | | | | | | — | | |
|
Stephen C. Petrovich(6)
|
| | | | 1,051,089 | | | | | | * | | | | | | 1,043,423 | | | | | | 7,666 | | | | | | * | | |
|
Neil Hemphill(7)
|
| | | | 790,596 | | | | | | * | | | | | | 790,596 | | | | | | — | | | | | | — | | |
| |
BofA Securities
|
| | Citigroup | | |
Leerink Partners
|
| |
Mizuho
|
|
| |
RBC Capital Markets
|
| |
Stephens Inc.
|
| |
Truist Securities
|
|
| | | | |
Capital One Securities
|
| | | |